2.89
-0.11(-3.67%)
Currency In USD
| Previous Close | 3 |
| Open | 2.98 |
| Day High | 3.04 |
| Day Low | 2.86 |
| 52-Week High | 19.5 |
| 52-Week Low | 1.45 |
| Volume | 274,790 |
| Average Volume | 873,334 |
| Market Cap | 95.94M |
| PE | -0.94 |
| EPS | -3.09 |
| Moving Average 50 Days | 3.09 |
| Moving Average 200 Days | 7.04 |
| Change | -0.11 |
If you invested $1000 in Lexeo Therapeutics, Inc. Common Stock (LXEO) since IPO date, it would be worth $295.6 as of May 09, 2025 at a share price of $2.971. Whereas If you bought $1000 worth of Lexeo Therapeutics, Inc. Common Stock (LXEO) shares 1 year ago, it would be worth $204.88 as of May 09, 2025 at a share price of $2.971.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Lexeo Therapeutics to Present New CMC Data at the 28th American Society of Gene & Cell Therapy (ASGCT) Annual Meeting
GlobeNewswire Inc.
May 01, 2025 1:16 PM GMT
Research highlights AAV manufacturing optimization via Lexeo’s Sf9-baculovirus processNEW YORK, May 01, 2025 (GLOBE NEWSWIRE) -- Lexeo Therapeutics, Inc. (Nasdaq: LXEO), a clinical stage genetic medicine company dedicated to pioneering novel treatm
Lexeo Therapeutics Announces Positive Interim Phase 1/2 Data for LX2006 in Friedreich Ataxia Cardiomyopathy Supporting Advancement to Registrational Study
GlobeNewswire Inc.
Apr 07, 2025 10:00 AM GMT
Participants with abnormal left ventricular mass index (LVMI) at baseline achieved 25% mean reduction in LVMI by 12 months or sooner Clinically meaningful improvements in majority of participants across cardiac biomarkers and functional measures All
Lexeo Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
GlobeNewswire Inc.
Jan 07, 2025 12:30 PM GMT
NEW YORK, Jan. 07, 2025 (GLOBE NEWSWIRE) -- Lexeo Therapeutics, Inc. (Nasdaq: LXEO), a clinical stage genetic medicine company dedicated to pioneering treatments for genetically defined cardiovascular diseases, today announced that R. Nolan Townsen